UnitedHealth Group (UHG) has been overcharging some cancer patients by more than 1,000 percent for live-changing drugs, a ...
AbbVie (NYSE:ABBV) has managed to keep its market share for its bestselling arthritis therapy, Humira, above 70%, generic ...
The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback